| Title : Poster: The use of the scopolamine-induced cognitive impairment model to translate on-target activity for ABT-894 from rodents\/monkeys to humans: Preclinical evidences - |
| Author(s) : Rueter LE , Relo AL , van Gaalen MM , Ballard ME , Terry AV, Jr. , Buccafusco JJ , Zhang M |
| Ref : Biochemical Pharmacology , 82 :1043 , 2011 |
| PubMedID: |
Rueter LE, Relo AL, van Gaalen MM, Ballard ME, Terry AV, Jr., Buccafusco JJ, Zhang M (2011)
Poster: The use of the scopolamine-induced cognitive impairment model to translate on-target activity for ABT-894 from rodents\/monkeys to humans: Preclinical evidences
Biochemical Pharmacology
82 :1043
Rueter LE, Relo AL, van Gaalen MM, Ballard ME, Terry AV, Jr., Buccafusco JJ, Zhang M (2011)
Biochemical Pharmacology
82 :1043
Array
(
[id] => 145138
[paper] => Rueter_2011_Biochem.Pharmacol_82(8)_1043
[author] => Rueter LE || Relo AL || van Gaalen MM || Ballard ME || Terry AV, Jr. || Buccafusco JJ || Zhang M
[year] => 2011
[title] => Poster: The use of the scopolamine-induced cognitive impairment model to translate on-target activity for ABT-894 from rodents\/monkeys to humans: Preclinical evidences
[journal] => Biochemical Pharmacology
[volume] => 82
[page] => 1043
[medline] =>
[abstract] =>
[kin_reference] =>
[mutation] =>
[kinetic_parameter] =>
[inhibitor] =>
[kin_value] =>
[substrate] =>
[gene_locus] => Array
(
)
[family] =>
[interact_gene_locus] =>
[xenobiotic_sensitivity] =>
[news] =>
[likid_reference] =>
[lip_reference] =>
[gene_locus_frgt] =>
[structure] =>
[comment] =>
[chemical] =>
[arpigny_jaeger] =>
[reactivator] =>
[disease] =>
[enzyme] =>
[risk_factor] =>
[tissue] =>
[sub_tissue] =>
[activity] =>
[specific_activity] =>
[disease_by_interaction] =>
[abstract_text] =>
)